Picture of Eris Lifesciences logo

ERIS — Eris Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedMid CapFalling Star

Brief: Eris Lifesciences Propose To Demerge Domestic Formulations Business Of Oaknet And Amalgamate It With Co

May 17 (Reuters) - Eris Lifesciences Ltd  ERIS.NS :
    * PROPOSE TO DEMERGE DOMESTIC FORMULATIONS BUSINESS OF
OAKNET AND
AMALGAMATE IT WITH CO, EFFECTIVE APRIL 1, 2024
    * COMMENCED OPERATIONAL INTEGRATION OF BUSINESSES; EXPECTED
TO BE
COMPLETED BY END OF JUNE 2023 
    * IN-SOURCED MANUFACTURING OF DERMATOLOGY FORMULATIONS AT
GUJARAT
FACILITY TARGETING FROM JAN 2024

Source text for Eikon:  ID:nBSE7nbL3S 
Further company coverage:  ERIS.NS 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Eris Lifesciences

See all news